Compare BCPC & CNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCPC | CNK |
|---|---|---|
| Founded | 1967 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Movies/Entertainment |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.5B |
| IPO Year | 1995 | 2007 |
| Metric | BCPC | CNK |
|---|---|---|
| Price | $172.76 | $41.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $213.50 | $44.27 |
| AVG Volume (30 Days) | 257.3K | ★ 2.0M |
| Earning Date | 10-23-2026 | 11-03-2026 |
| Dividend Yield | 0.23% | ★ 0.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.09 | N/A |
| Revenue | $799,023,000.00 | ★ $3,115,000,000.00 |
| Revenue This Year | $9.17 | $18.18 |
| Revenue Next Year | $5.91 | $1.20 |
| P/E Ratio | $42.70 | ★ N/A |
| Revenue Growth | ★ 13.56 | 2.15 |
| 52 Week Low | $147.18 | $21.60 |
| 52 Week High | $186.15 | $41.67 |
| Indicator | BCPC | CNK |
|---|---|---|
| Relative Strength Index (RSI) | 49.15 | 62.16 |
| Support Level | $159.44 | $36.39 |
| Resistance Level | $176.54 | N/A |
| Average True Range (ATR) | 4.74 | 1.49 |
| MACD | -0.02 | 0.09 |
| Stochastic Oscillator | 30.47 | 91.97 |
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres. Cinemark manages its business under two reportable segments: U.S. markets and international markets. The majority of its revenue is generated from the U.S. markets segment.